{
    "PubTator3": [
        {
            "_id": "38980086|None",
            "id": "38980086",
            "infons": {},
            "passages": [
                {
                    "infons": {
                        "journal": "Expert Rev Neurother;2024Jul09 1. doi:10.1080/14737175.2024.2376840",
                        "year": "2024",
                        "type": "title",
                        "authors": "Beaudin M, Dupre N, Manto M, "
                    },
                    "offset": 0,
                    "text": "The importance of synthetic pharmacotherapy for recessive cerebellar ataxias.",
                    "sentences": [],
                    "annotations": [],
                    "relations": []
                },
                {
                    "infons": {
                        "type": "abstract"
                    },
                    "offset": 78,
                    "text": "INTRODUCTION: The last decade has witnessed major breakthroughs in identifying novel genetic causes of hereditary ataxias, deepening our understanding of disease mechanisms, and developing therapies for these debilitating disorders. AREAS COVERED: This article reviews the currently approved and most promising candidate pharmacotherapies in relation to the known disease mechanisms of the most prevalent autosomal recessive ataxias. Omaveloxolone is an Nrf2 activator that increases antioxidant defense and was recently approved for treatment of Friedreich ataxia. Its therapeutic effect is modest, and further research is needed to find synergistic treatments that would halt or reverse disease progression. Promising approaches include upregulation of frataxin expression by epigenetic mechanisms, direct protein replacement, and gene replacement therapy. For ataxia-telangiectasia, promising approaches include splice-switching antisense oligonucleotides and small molecules targeting oxidative stress, inflammation, and mitochondrial function. Rare recessive ataxias for which disease-modifying therapies exist are also reviewed, emphasizing recently approved therapies. Evidence supporting the use of riluzole and acetyl-leucine in recessive ataxias is discussed. EXPERT OPINION: Advances in genetic therapies for other neurogenetic conditions have paved the way to implement feasible approaches with potential dramatic benefits. Particularly, as we develop effective treatments for these conditions, we may need to combine therapies, consider newborn testing for pre-symptomatic treatment, and optimize non-pharmacological approaches.",
                    "sentences": [],
                    "annotations": [
                        {
                            "id": "7",
                            "infons": {
                                "identifier": "MESH:C000589490",
                                "type": "Chemical",
                                "valid": true,
                                "normalized": [
                                    "C000589490"
                                ],
                                "database": "ncbi_mesh",
                                "normalized_id": "C000589490",
                                "biotype": "chemical",
                                "name": "omaveloxolone",
                                "accession": "@CHEMICAL_omaveloxolone"
                            },
                            "text": "Omaveloxolone",
                            "locations": [
                                {
                                    "offset": 512,
                                    "length": 13
                                }
                            ]
                        },
                        {
                            "id": "8",
                            "infons": {
                                "identifier": "4780",
                                "type": "Gene",
                                "ncbi_homologene": "2412",
                                "valid": true,
                                "normalized": [
                                    4780
                                ],
                                "database": "ncbi_gene",
                                "normalized_id": 4780,
                                "biotype": "gene",
                                "name": "NFE2L2",
                                "accession": "@GENE_NFE2L2"
                            },
                            "text": "Nrf2",
                            "locations": [
                                {
                                    "offset": 532,
                                    "length": 4
                                }
                            ]
                        },
                        {
                            "id": "9",
                            "infons": {
                                "identifier": "2395",
                                "type": "Gene",
                                "ncbi_homologene": "47908",
                                "valid": true,
                                "normalized": [
                                    2395
                                ],
                                "database": "ncbi_gene",
                                "normalized_id": 2395,
                                "biotype": "gene",
                                "name": "FXN",
                                "accession": "@GENE_FXN"
                            },
                            "text": "frataxin",
                            "locations": [
                                {
                                    "offset": 833,
                                    "length": 8
                                }
                            ]
                        },
                        {
                            "id": "10",
                            "infons": {
                                "identifier": "-",
                                "type": "Chemical",
                                "valid": false,
                                "normalized_id": null,
                                "biotype": "chemical"
                            },
                            "text": "antisense",
                            "locations": [
                                {
                                    "offset": 1010,
                                    "length": 9
                                }
                            ]
                        },
                        {
                            "id": "11",
                            "infons": {
                                "identifier": "MESH:D009841",
                                "type": "Chemical",
                                "valid": true,
                                "normalized": [
                                    "D009841"
                                ],
                                "database": "ncbi_mesh",
                                "normalized_id": "D009841",
                                "biotype": "chemical",
                                "name": "Oligonucleotides",
                                "accession": "@CHEMICAL_Oligonucleotides"
                            },
                            "text": "oligonucleotides",
                            "locations": [
                                {
                                    "offset": 1020,
                                    "length": 16
                                }
                            ]
                        },
                        {
                            "id": "12",
                            "infons": {
                                "identifier": "MESH:D019782",
                                "type": "Chemical",
                                "valid": true,
                                "normalized": [
                                    "D019782"
                                ],
                                "database": "ncbi_mesh",
                                "normalized_id": "D019782",
                                "biotype": "chemical",
                                "name": "Riluzole",
                                "accession": "@CHEMICAL_Riluzole"
                            },
                            "text": "riluzole",
                            "locations": [
                                {
                                    "offset": 1285,
                                    "length": 8
                                }
                            ]
                        },
                        {
                            "id": "13",
                            "infons": {
                                "identifier": "MESH:C088117",
                                "type": "Chemical",
                                "valid": true,
                                "normalized": [
                                    "C088117"
                                ],
                                "database": "ncbi_mesh",
                                "normalized_id": "C088117",
                                "biotype": "chemical",
                                "name": "acetylleucine",
                                "accession": "@CHEMICAL_acetylleucine"
                            },
                            "text": "acetyl-leucine",
                            "locations": [
                                {
                                    "offset": 1298,
                                    "length": 14
                                }
                            ]
                        }
                    ],
                    "relations": []
                }
            ],
            "relations": [
                {
                    "id": "R1",
                    "infons": {
                        "score": "0.9985",
                        "role1": {
                            "identifier": "MESH:C000589490",
                            "type": "Chemical",
                            "valid": true,
                            "normalized": [
                                "C000589490"
                            ],
                            "database": "ncbi_mesh",
                            "normalized_id": "C000589490",
                            "biotype": "chemical",
                            "name": "omaveloxolone",
                            "accession": "@CHEMICAL_omaveloxolone"
                        },
                        "role2": {
                            "identifier": "4780",
                            "type": "Gene",
                            "valid": true,
                            "normalized": [
                                4780
                            ],
                            "database": "ncbi_gene",
                            "normalized_id": 4780,
                            "biotype": "gene",
                            "name": "NFE2L2",
                            "accession": "@GENE_NFE2L2"
                        },
                        "type": "Positive_Correlation"
                    },
                    "nodes": [
                        {
                            "refid": "0",
                            "role": "0,1"
                        }
                    ]
                }
            ],
            "pmid": 38980086,
            "pmcid": null,
            "meta": {},
            "date": "2024-07-09T00:00:00Z",
            "journal": "Expert Rev Neurother",
            "authors": [
                "Beaudin M",
                "Dupre N",
                "Manto M"
            ],
            "relations_display": [
                {
                    "name": "positive_correlate|@CHEMICAL_omaveloxolone|@GENE_NFE2L2"
                }
            ]
        }
    ]
}